Publication | Closed Access

An open multicenter phase II trial of docetaxel–gemcitabine in Charlson score and performance status (PS) selected elderly patients with stage IIIB pleura/IV non-small-cell lung cancer (NSCLC): The GFPC 02-02a study

Gfpc 02-02A StudyOncologyHealth SciencesElderly PatientsAdvanced Lung DiseaseClinical TrialsCancer TreatmentMedicineRadiation OncologyLung CancerRadiologyCharlson Score